On Air Now

Current Show

Maria Danza   10:00 AM - 11:00 AM

It's The Morning Jam with Maria Danza

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
40° Feels Like: 33°
Wind: ENE 10 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 57°

Tonight

Cloudy 41°

Tomorrow

Cloudy 62°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Actelion buys U.S.-based firm with cancer drug in development

A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann

ZURICH (Reuters) - Actelion said it will acquire Ceptaris, a privately held U.S.-based specialty pharmaceutical company developing a topical drug, Valchlor, to treat a form of cancer.

Allschwil-based Actelion said it already paid Ceptaris $25 million and will pay another $225 million when the deal closes. The deal is contingent on Valchlor clinching approval from the U.S. health regulator.

"We expect the transaction to become cash-accretive before the end of 2014," Actelion executive Nicholas Franco said in a statement on Wednesday.

(Reporting By Katharina Bart)

Comments